73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
What do you know about these three rare childhood cancers?

What do you know about these three rare childhood cancers?

by Laurel KellyCredit: Unsplash/CC0 Public DomainChildhood cancer rates have been rising slightly for the past few decades, and about 10,470 children in the U.S. under the age of 15 will be diagnosed

What do you know about these three rare childhood cancers?

by Laurel KellyCredit: Unsplash/CC0 Public DomainChildhood cancer rates have been rising slightly for the past few decades, and about 10,470 children in the U.S. under the age of 15 will be diagnosed
Researchers conduct clinical trial of a specific drug combination for lethal brain cancer glioblastoma

Researchers conduct clinical trial of a specific drug combination for lethal brain cancer glioblastoma

by Will Sansom,University of Texas Health Science Center at San AntonioCredit: Pixabay/CC0 Public DomainThe Mays Cancer Center at The University of Texas Health Science Center at San Antonio rec

Researchers conduct clinical trial of a specific drug combination for lethal brain cancer glioblastoma

by Will Sansom,University of Texas Health Science Center at San AntonioCredit: Pixabay/CC0 Public DomainThe Mays Cancer Center at The University of Texas Health Science Center at San Antonio rec
Direct oral anticoagulant therapy found to be feasible for cancer patients

Direct oral anticoagulant therapy found to be feasible for cancer patients

by Lori SolomonDirect oral anticoagulant (DOAC) treatment is noninferior to low-molecular-weight heparin (LMWH) for preventing recurrent venous thromboembolism (VTE) in cancer patients, according to a

Direct oral anticoagulant therapy found to be feasible for cancer patients

by Lori SolomonDirect oral anticoagulant (DOAC) treatment is noninferior to low-molecular-weight heparin (LMWH) for preventing recurrent venous thromboembolism (VTE) in cancer patients, according to a
Researchers identify women with twice the risk of cancer in both breasts

Researchers identify women with twice the risk of cancer in both breasts

by Mayo ClinicCumulative incidence of CBC risk in PV carriers. Cumulative incidence plots for first contralateral breast cancers after primary breast cancer. Cumulative incidence is plotted again

Researchers identify women with twice the risk of cancer in both breasts

by Mayo ClinicCumulative incidence of CBC risk in PV carriers. Cumulative incidence plots for first contralateral breast cancers after primary breast cancer. Cumulative incidence is plotted again
Drug compound could be next-generation treatment for aggressive form of leukemia

Drug compound could be next-generation treatment for aggressive form of leukemia

by Tom Coyne,Purdue UniversityHerman Sintim, the Drug Discovery Professor of Chemistry in Purdue University's Department of Chemistry, is leading a team of researchers developing a series of

Drug compound could be next-generation treatment for aggressive form of leukemia

by Tom Coyne,Purdue UniversityHerman Sintim, the Drug Discovery Professor of Chemistry in Purdue University's Department of Chemistry, is leading a team of researchers developing a series of
The search to discover why 'outliers' survive deadliest cancers

The search to discover why 'outliers' survive deadliest cancers

by Isabelle TOURNÉThe biotech start-up Cure51 is working on the first global molecular database of exceptional survivors of cancer.When Herve found out he had glioblastoma—the most aggressive form of

The search to discover why 'outliers' survive deadliest cancers

by Isabelle TOURNÉThe biotech start-up Cure51 is working on the first global molecular database of exceptional survivors of cancer.When Herve found out he had glioblastoma—the most aggressive form of
Genetic variation enhances cancer drug sensitivity in specific patient groups, study shows

Genetic variation enhances cancer drug sensitivity in specific patient groups, study shows

byUppsala UniversityA graphical summary illustrates the strategy used to identify CYP2D6 as a target for collateral lethality, which is driven by the widespread occurrence of loss of heterozygos

Genetic variation enhances cancer drug sensitivity in specific patient groups, study shows

byUppsala UniversityA graphical summary illustrates the strategy used to identify CYP2D6 as a target for collateral lethality, which is driven by the widespread occurrence of loss of heterozygos
Study deciphers packaging of tumor 'cargo,' leading to better understanding of how cancers spread

Study deciphers packaging of tumor 'cargo,' leading to better understanding of how cancers spread

by Deanna Csomo Mccool,University of Notre DameCredit: Crislyn D’Souza-SchoreyResearchers at the University of Notre Dame have outlined the delivery mechanism tumor cells use to move nucleic aci

Study deciphers packaging of tumor 'cargo,' leading to better understanding of how cancers spread

by Deanna Csomo Mccool,University of Notre DameCredit: Crislyn D’Souza-SchoreyResearchers at the University of Notre Dame have outlined the delivery mechanism tumor cells use to move nucleic aci
Study: Women more likely to postpone cancer screening than men during COVID-19 pandemic

Study: Women more likely to postpone cancer screening than men during COVID-19 pandemic

by eLifeCredit: Unsplash/CC0 Public DomainResearchers have revealed differences in cancer screening uptake during the pandemic according to people's sex, age, education, race and ethnicity.Th

Study: Women more likely to postpone cancer screening than men during COVID-19 pandemic

by eLifeCredit: Unsplash/CC0 Public DomainResearchers have revealed differences in cancer screening uptake during the pandemic according to people's sex, age, education, race and ethnicity.Th
Researchers develop insights into KRAS mutations in pancreatic cancers

Researchers develop insights into KRAS mutations in pancreatic cancers

byWeill Cornell Medical CollegeSpatial molecular profiling of a resected pancreatic adenocarcinoma. Fluorescently-labeled probes bind to RNA targets to identify the location of different cell ty

Researchers develop insights into KRAS mutations in pancreatic cancers

byWeill Cornell Medical CollegeSpatial molecular profiling of a resected pancreatic adenocarcinoma. Fluorescently-labeled probes bind to RNA targets to identify the location of different cell ty
First line immunotherapy combination fails to improve overall survival in lung cancer

First line immunotherapy combination fails to improve overall survival in lung cancer

by European Society for Medical OncologyStudy author Dr Naiyer Rizvi, director of thoracic oncology and immunotherapeutics, Columbia University Medical Center, New York, US. Credit: © European So

First line immunotherapy combination fails to improve overall survival in lung cancer

by European Society for Medical OncologyStudy author Dr Naiyer Rizvi, director of thoracic oncology and immunotherapeutics, Columbia University Medical Center, New York, US. Credit: © European So
An accurate integrated imaging and projection system for oral cancer diagnosis

An accurate integrated imaging and projection system for oral cancer diagnosis

by SPIEImaging workflow of the ABGS. Step 1: widefield images are acquired using the camera and projector. Step 2: a cancer risk map is generated and projected onto the oral cavity. Step 3: multi

An accurate integrated imaging and projection system for oral cancer diagnosis

by SPIEImaging workflow of the ABGS. Step 1: widefield images are acquired using the camera and projector. Step 2: a cancer risk map is generated and projected onto the oral cavity. Step 3: multi